作者
Ji Man Hong,Jin Soo Lee,Yeong‐Bae Lee,Dong Hoon Shin,Dong‐Ick Shin,Yang‐Ha Hwang,Seong Hwan Ahn,Jae Guk Kim,Sung‐Il Sohn,Sun U. Kwon,Ji Sung Lee,Byoung Joo Gwag,Ángel Chamorro,Dennis W. Choi,Ángel Chammorro,Eung Yeop Kim,Jin Wook Choi,Min-Ju Yeo,Jae-Hyuk Kwak,Sung Eun Lee,Jeong‐Ho Hong,Sang Kil Lee,Yoon-Joo Lee,Min-Joo Lee
摘要
Nelonemdaz is a multitarget neuroprotectant that selectively blocks N-methyl-D-aspartate receptors and scavenges free radicals, as proven in preclinical ischemia-reperfusion studies. We aimed to evaluate the safety and efficacy of nelonemdaz in patients with acute ischemic stroke receiving endovascular reperfusion therapy.